First Trust Capital Strength ETF (FTCS)
Live price chart, market sentiment, and community perspectives for First Trust Capital Strength ETF (NASDAQ: FTCS).
Live price chart, market sentiment, and community perspectives for First Trust Capital Strength ETF (NASDAQ: FTCS).
On our desk, we are tracking the $8.02B asset scale of FTCS as a testament to First Trust's distribution strength, yet the underlying large-cap blend exposure feels sluggish. While Morningstar assigns it a Low risk rating across multi-year windows, our quantitative models show that this risk discount fails to translate into competitive returns, making it a difficult sell for aggressive institutional mandates.
Looking at the 3-year and 5-year metrics, the 0.51 beta and 10.6% standard deviation confirm that FTCS is exceptionally defensive. However, the 5-year Sharpe ratio of 0.23 significantly lags the category's 0.50. Investors are paying a hidden opportunity cost because the upside capture sits at a meager 65, missing out on broad market rallies.
When evaluating predictive signals for FTCS, our quantitative systems highlight an interesting technical setup: neutral short-to-mid term sentiment is prevailing, but there are no remaining overhead resistance levels above current price prints around 100.45, creating a theoretical pathway for upside continuation if momentum shifts.
As a risk manager, I appreciate that FTCS delivered a shallower 5-year worst drawdown of -20.9% compared to the -23.3% category average. That being said, the structural underperformance in bull markets makes it less attractive for clients seeking efficient growth rather than pure capital preservation.
In our portfolio reviews, FTCS continues to be scrutinized for its low return vs. category profile across all observed windows. Despite holding large-cap blend constituents with stable cash flows, the strategy's risk reduction features have consistently hindered its ability to match benchmark growth metrics.
Explore plasma cleansing, somatic organ swaps, and BCI.